| Net Loss per Share of Common Stock |
Note 13. Net Loss per Share of Common Stock For the three and six months ended June 30, 2026 and June 30, 2025, basic earnings per hare has been calculated by dividing net earnings attributable to Common Stock by the weighted average number of shares of Common Stock outstanding for the same period. Share of Common Stock are weighted for the portion of the period in which the shares were outstanding. Dilutive earnings per share has been calculated in a manner consistent with that of basic earnings per share while considering all potentially dilutive shares of Common Stock outstanding during the period. The following table set forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2026 and June 30, 2025. | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Basic numerator: | | | | | | | | | | | | | Net loss attributable to XWELL, Inc. | | $ | (2,240) | | $ | (2,269) | | $ | (13,442) | | $ | (6,988) | Less: preferred stock dividends | | | — | | | (189) | | | (82) | | | (257) | Less: preferred stock accretion | | | — | | | (583) | | | — | | | (1,082) | Plus: deemed contribution on Repurchase of Series G Preferred Stock | | | — | | | — | | | 106 | | | — | Net loss attributable to common shareholders | | $ | (2,240) | | $ | (3,041) | | $ | (13,418) | | $ | (8,327) | Basic denominator: | | | | | | | | | | | | | Basic weighted average shares outstanding | | | 8,487,425 | | | 5,417,271 | | | 7,944,801 | | | 5,340,442 | Basic loss per share | | $ | (0.26) | | $ | (0.56) | | $ | (1.69) | | $ | (1.56) | | | | | | | | | | | | | | Net loss per share data presented above excludes from the calculation of diluted net loss, the following potentially dilutive securities, having an anti-dilutive impact, in case of net loss | | | | | | | | | | | | | Both vested and unvested options to purchase an equal number of shares of Common Stock | | | 899,123 | | | 944,554 | | | 899,123 | | | 944,554 | Unvested RSUs to issue an equal number of shares of Common Stock | | | 20,000 | | | 30,000 | | | 20,000 | | | 30,000 | Warrants to purchase shares of Common Stock | | | 71,999,234 | | | — | | | 71,999,234 | | | — | Series A and Series B warrants to purchase shares of Common Stock | | | — | | | 5,347,594 | | | — | | | 5,347,594 | Series G Convertible Preferred Stock on an as converted basis | | | — | | | 2,406,417 | | | — | | | 2,406,417 | Series H Convertible Preferred Stock on an as converted basis | | | 66,665,957 | | | — | | | 66,665,957 | | | — | Total number of potentially dilutive securities excluded from the calculation of loss per share attributable to common shareholders | | | 139,584,314 | | | 8,728,565 | | | 139,584,314 | | | 8,728,565 |
|